02877.HK
China Shineway Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 8.13
−2.11%Margins
Gross margin
71.3%
EBITDA margin
29.9%
EBIT margin
24.4%
Net margin
30.1%
FCF margin
36.8%
9.7%
Return on equity
7.6%
Return on assets
7.6%
Return on invested capital
0.25x
Asset turnover
HKD 1.4B
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026